Looking at the filing, I can identify it as a Form 10-Q for USANA Health Sciences, Inc., trading as USNA on the New York Stock Exchange, for the quarterly period ended July 4, 2026. Let me assess the substantive disclosure content. The filing text provided contains primarily: the cover page, table of contents, and the cautionary note regarding forward-looking statements. The financial statements, MD&A, and other substantive financial data sections are referenced in the table of contents but not included in the extracted text. The substantive disclosure content (excluding cover page, boilerplate, cautionary language, table of contents, and exhibit lists) is essentially the risk factor bullets in the forward-looking statements section. Let me count those substantive points... The risk bullets do contain meaningful company-specific disclosures about business operations, acquisitions (Hiya Health Products, LLC and Rise Wellness, Inc.), and business model details. This content exceeds 150 words of substantive disclosure.

USANA Health Sciences, Inc. filed its Form 10-Q with the SEC on August 13, 2026, covering the quarterly period ended July 4, 2026, and reporting 18,476,534 shares of common stock outstanding as of August 11, 2026.

Key Highlights

  • Shares outstanding: As of August 11, 2026, there were 18,476,534 outstanding shares of common stock with a par value of $0.001.
  • Accelerated filer status: The company is classified as an accelerated filer, and not a large accelerated filer, smaller reporting company, or emerging growth company.
  • Acquired businesses: The filing identifies two acquired direct-to-consumer businesses: Hiya Health Products, LLC ("Hiya") and Rise Wellness, Inc. ("Rise").
  • Core business trend: According to the filing, the Core Nutritional direct sales business "has experienced a decline in net sales, net income and active Customers over the last few years."
  • China operations: The company operates its Core Nutritional business in China through its subsidiary BabyCare Holdings, Ltd. ("BabyCare").
  • Auditor: KPMG LLP, located in Salt Lake City, Utah (Firm ID: 185), serves as the company's auditor.

USANA Discloses Omni-Channel Shift and Ongoing Core Business Decline

USANA Health Sciences, Inc. (NYSE:USNA), headquartered at 3838 West Parkway Blvd., Salt Lake City, Utah 84120, filed its quarterly report for the period ended July 4, 2026. The filing describes the company as evolving from a traditional direct sales model into what the filing calls "an omni-channel health and wellness company," with growth outside its Core Nutritional business depending on its acquired subsidiaries, Hiya Health Products, LLC and Rise Wellness, Inc., operating in direct-to-consumer, retail, and online marketplace channels.

The filing acknowledges that the Core Nutritional direct sales business, which relies on independent Brand Partners (formerly referred to as "Associates"), "has experienced a decline in net sales, net income and active Customers over the last few years," according to the registrant's own disclosure. The company also cited risks related to its Brand Partner Compensation Plan, product liability, and regulatory requirements across international markets, including direct selling regulations in the United States and China.

Regarding China, the filing flags several risk areas tied to BabyCare Holdings, Ltd., the subsidiary through which USANA conducts its Core Nutritional business in that market. These include general risks of operating in China, compliance with direct selling regulations there, data privacy and security laws, and changes in the Chinese economy or consumer environment. The filing also notes risks from export control and trade sanctions laws, as well as macroeconomic conditions. The forward-looking statements included in this report are the company's own and are subject to its cautionary language as described in the filing.

What Was Disclosed

USANA Health Sciences filed its quarterly report for the period ended July 4, 2026, disclosing 18,476,534 shares outstanding, its accelerated filer status, the identities of two acquired subsidiaries, ongoing declines in its Core Nutritional business, and key operational risks including China regulatory exposure.